Antimicrobial Therapies
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
44
NCT06044844
Effectiveness of Tofacitinib in Systemic Sclerosis
Phase: Phase 2
Role: Collaborator
Start: Nov 30, 2023
Completion: May 31, 2024
Loading map...